TickerFacts.

USANA Health Sciences Inc (USNA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$69.99M
Year ended 2026-01-03, Fiscal 2025
$31.35M
Trailing 12 months to 2026-07-04
-16.7%
3-year compound annual growth
-18.1%
5-year compound annual growth
-7.4%
10-year compound annual growth
$205.20M2010-01-02: $57.86M2011-01-01: $76.13M2011-12-31: $85.73M2012-12-29: $107.00M2013-12-28: $125.76M2015-01-03: $124.91M2016-01-02: $151.64M2016-12-31: $152.10M2017-12-30: $148.61M2018-12-29: $205.20M2019-12-28: $160.93M2021-01-02: $190.24M2022-01-01: $183.23M2022-12-31: $121.01M2023-12-30: $105.77M2024-12-28: $80.86M2026-01-03: $69.99M$69.99M
2010-01-02 EBITDA (USD) 2026-01-03
Period endedEBITDAChange YoYSource filing
2026-01-03, Fiscal 2025$69.99M-13.4%2026-03-16, From 2024-12-29
2024-12-28$80.86M-23.6%2026-03-16, From 2023-12-31
2023-12-30$105.77M-12.6%2026-03-16, From 2023-01-01
2022-12-31$121.01M-34.0%2025-03-12, From 2022-01-02
2022-01-01, Fiscal 2021$183.23M-3.7%2024-02-27, From 2021-01-03
2021-01-02, Fiscal 2020$190.24M+18.2%2023-02-28, From 2019-12-29
2019-12-28$160.93M-21.6%2022-03-01, From 2018-12-30
2018-12-29$205.20M+38.1%2021-03-02, From 2017-12-31
2017-12-30$148.61M-2.3%2020-02-25, From 2017-01-01
2016-12-31$152.10M+0.3%2019-02-26, From 2016-01-03
2016-01-02, Fiscal 2015$151.64M+21.4%2018-02-28, From 2015-01-04
2015-01-03, Fiscal 2014$124.91M-0.7%2017-03-01, From 2013-12-29
2013-12-28$125.76M+17.5%2016-03-01, From 2012-12-30
2012-12-29$107.00M+24.8%2015-03-17, From 2012-01-01
2011-12-31$85.73M+12.6%2014-03-13, From 2011-01-02
2011-01-01, Fiscal 2010$76.13M+31.6%2013-03-11, From 2010-01-03
2010-01-02, Fiscal 2009$57.86Mn/a2012-03-14, From 2009-01-04

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
USANA Health Sciences Inc (USNA)2026-01-03$69.99M-13.4%
Trulieve Cannabis Corp. (TRLV)2025-12-31$261.13M+24.0%
Curaleaf Holdings, Inc. (CURLF)2025-12-31$222.06M-13.3%
Cresco Labs Inc. (CRLBF)2025-12-31$20.73M-87.5%
Ascend Wellness Holdings, Inc. (AAWH)2025-12-31$56.52M-20.3%
Jushi Holdings Inc. (JUSH)2025-12-31$35.84M-12.1%
biote Corp. (BTMD)2025-12-31$39.22M+11.5%
Glass House Brands Inc. (GLAS)2025-12-31-$1.53Mn/m
Marimed Inc. (MRMD)2025-12-31$5.29M-49.7%

Compare USNA, TRLV, CURLF, CRLBF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗